TABLE 1.
HD individual | Age | Gender | CAG Repeats | CAP Score- Fneur | Disease Severity | Figure Number |
---|---|---|---|---|---|---|
GM02165 | 57 YR | Male | 46 a | 140.5239 | Severe | 4 |
GM05031 | 60 YR | Male | 45 a | 138.6749 | Severe | 4 |
GM04476 | 57 YR | Male | 45 b | 131.7411 | Severe | 1,2,3,4 |
GM04200 | 53 YR | Male | 46 a | 130.6626 | Severe | 4 |
GM00305 | 56 YR | Female | 45 a | 129.4299 | Severe | 4 |
GM04285 | 40 YR | Male | 51 b | 129.4299 | Severe | 4 |
GM06274 | 56 YR | Female | 45 a | 129.4299 | Severe | 1,4 |
GM04807 | 41 YR | Male | 50 b | 126.3482 | Severe | 4 |
GM04287 | 43 YR | Male | 49 b | 125.886 | Severe | 1,2,4,5 |
GM02147 | 55 YR | Male | 44 a | 118.6441 | Severe | 4 |
GM04691 | 31 YR | Male | 54 b | 114.6379 | Severe | 4 |
GM04687 | 37 YR | Female | 50 b | 114.0216 | Severe | 4 |
GM04709 | 38 YR | Female | 49 b | 111.2481 | Mild | 1,2,3,4,5 |
GM04715 | 40 YR | Male | 48 b | 110.9399 | Mild | 3,4,5 |
GM04887 | 48 YR | Female | 45 b | 110.9399 | Mild | 1,2,3,4 |
GM04196 | 51 YR | Female | 44 a | 110.0154 | Mild | 1,2,4 |
GM04767 | 43 YR | Female | 46 b | 106.0092 | Mild | 4 |
GM04849 | 28 YR | Female | 54 a | 103.5439 | Mild | 4 |
GM04212 | 50 YR | Female | 43 a | 100.1541 | Mild | 1,2,4,5 |
GM04819 | 48 YR | Male | 43 b | 96.14792 | Mild | 1,2,4,5 |
GM04799 | 47 YR | Male | 43 b | 94.14484 | Mild | 1,2,4 |
GM04721 | 37 YR | Female | 46 b | 91.21726 | Mild | 1,2,3,4 |
GM04719 | 39 YR | Female | 44 b | 84.12943 | Premanifest | 1,2,4 |
GM04847 | 31 YR | Male | 46 b | 76.42527 | Premanifest | 4 |
GM04693 | 33 YR | Male | 45 b | 76.27119 | Premanifest | 4 |
GM04717 | 44 YR | Female | 41 b | 74.57627 | Premanifest | 1,2,3,4 |
GM04689 | 30 YR | Female | 45 b | 69.33744 | Premanifest | 4 |
GM04837 | 23 YR | Male | 47 b | 60.24653 | Premanifest | 4 |
CAG repeat number of the HD sample was obtained using AmplideX® PCR/CE HTT Kit following the manufacturers protocol guidelines.
CAG repeat number of the HD sample was provided by Coriell Institute Cell Repository.